{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:04:33Z","timestamp":1781877873891,"version":"3.54.5"},"reference-count":19,"publisher":"Danish Medical Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dan Med J"],"abstract":"<jats:p>INTRODUCTION. Cellulitis is a common infection, especially among the elderly, and compression therapy is often recommended to reduce acute oedema and pain. A previous study showed that compression therapy led to a lower incidence of recurrent cellulitis in lower extremities in patients with chronic oedema. The aim of this study was to describe clinical characteristics of patients with cellulitis.  METHODS. This was a retrospective descriptive study reviewing medical records and medicine registrations in patients \u2265 18 years with cellulitis.  RESULTS. A total of 104 patients were hospitalised with cellulitis; 13 were excluded. The median age was 75 years (range: 33-103 years), 64% &gt; 70 years. The median admission time was five days (range: 1-24 days). Median antibiotic treatment duration was 11 days (range: 4-56 days). A total of 45% were current or former smokers, 40% were overweight, 48% had preexisting chronic oedema of the affected area, 90% had become infected in the lower extremities and 19% were readmitted within six months. A total of 51% had a new antibiotic treatment prescribed after being discharged, and 66% received compression therapy.  CONCLUSIONS. Cellulitis frequently affects older patients, especially smokers, people with overweight and chronic lymphoedema. In all, 66% were treated with compression therapy that did not have a clear effect on their readmission rate, probably because the patients receiving compression therapy had a more severe infection complicated by severe oedema and a higher risk of reinfection. An increased focus on the use of compression therapy in conjunction with health preventive interventions may have a positive impact on the relapse rate.  FUNDING. None.  TRIAL REGISTRATION. Not relevant.<\/jats:p>","DOI":"10.61409\/a08230530","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T08:51:19Z","timestamp":1712134279000},"page":"1-7","source":"Crossref","is-referenced-by-count":1,"title":["Use of compression therapy for cellulitis"],"prefix":"10.61409","volume":"71","author":[{"given":"Mia","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Midttun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"40208","published-online":{"date-parts":[[2024,4,1]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Damstra RJ, van Steensel MAM, Boomsma JHB et al. Erysipelas as a sign of subclinical primary lymphoedema: a prospective quantitative scintigraphic study of 40 patients with unilateral erysipelas of the leg. Br J Dermatol. 2008;158(6):1210-5. doi: https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08503.x","DOI":"10.1111\/j.1365-2133.2008.08503.x"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Webb E, Neeman T, Bowden FJ et al. Compression therapy to prevent recurrent cellulitis of the leg. N Engl J Med. 2020;383:630-9. doi: https:\/\/doi.org\/10.1056\/NEJMoa1917197","DOI":"10.1056\/NEJMoa1917197"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Rabe E, Partsch H, Morrison N et al. Risks and contraindications of medical compression treatment - a critical reappraisal. An international consensus statement. Phlebology. 2020;35(7):447-60. doi: https:\/\/doi.org\/10.1177\/0268355520909066","DOI":"10.1177\/0268355520909066"},{"key":"ref3","unstructured":"Villefrance M, H\u00f8gh A, Kristensen LH. Compression is important in erysipelas treatment. Ugeskr L\u00e6ger. 2017;179:V04170284."},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Bojesen S, Midttun M, Wiese L. Compression bandaging does not compromise peripheral microcirculation in patients with cellulitis of the lower leg. Eur J Dermatol. 2019;29(4):396-400. doi: https:\/\/doi.org\/10.1684\/ejd.2019.3606","DOI":"10.1684\/ejd.2019.3606"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Vaillant L, Gironet N. Infectious complications of lymphedema. Rev Med Interne. 2002;23(suppl 3):403s-407s. doi: https:\/\/doi.org\/10.1016\/S0248-8663(02)80383-6","DOI":"10.1016\/S0248-8663(02)80383-6"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Cox NH. Oedema as a risk factor for multiple episodes of cellulitis\/erysipelas of the lower leg: a series with community follow-up. Br J Dermatol. 2006;155(5):947-50. doi: https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07419.x","DOI":"10.1111\/j.1365-2133.2006.07419.x"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Midttun M, Ahmadzay NF, Henriksen JH. Does comprilan bandage have any influence on peripheral perfusion in patients with oedema? Clin Physiol Funct Imaging. 2010;30(5):323-7. doi: https:\/\/doi.org\/10.1111\/j.1475-097X.2010.00945.x","DOI":"10.1111\/j.1475-097X.2010.00945.x"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Bl\u00e4ckberg A, Trell K, Rasmussen M. Erysipelas, a large retrospective study of aetiology and clinical presentation. BMC Infect Dis. 2015;15:402. doi: https:\/\/doi.org\/10.1186\/s12879-015-1134-2","DOI":"10.1186\/s12879-015-1134-2"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Inghammar M, Rasmussen M, Linder A. Recurrent erysipelas - risk factors and clinical presentation. BMC Infect Dis. 2014;14:270. doi: https:\/\/doi.org\/10.1186\/1471-2334-14-270","DOI":"10.1186\/1471-2334-14-270"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Brishkoska-Boshkovski V, Kondova-Topuzovska I, Damevska K et al. Comorbidities as risk factors for acute and recurrent erysipelas. Open Access Maced J Med Sci. 2019;7(6):937-42. doi: https:\/\/doi.org\/10.3889\/oamjms.2019.214","DOI":"10.3889\/oamjms.2019.214"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Bruun T, Oppegaard O, Kittang BR et al. Etiology of cellulitis and clinical prediction of streptococcal disease: a prospective study. Open Forum Infect Dis. 2015;3(1):ofv181. doi: https:\/\/doi.org\/10.1093\/ofid\/ofv181","DOI":"10.1093\/ofid\/ofv181"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Garg A, Lavian J, Lin G et al. Clinical characteristics associated with days to discharge among patients admitted with a primary diagnosis of lower limb cellulitis. J Am Acad Dermatol. 2017;76(4):626-31. doi: https:\/\/doi.org\/10.1016\/j.jaad.2016.11.063","DOI":"10.1016\/j.jaad.2016.11.063"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Roda \u00c2, Pinto AM, Filipe AR et al. Clinical and laboratory factors associated with prolonged hospital stay among patients with cellulitis\/erysipelas. Acta Med Port. 2019;32(6):448-52. doi: https:\/\/doi.org\/10.20344\/amp.10735","DOI":"10.20344\/amp.10735"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Cross ELA, Jordan H, Godfrey R et al. Route and duration of antibiotic therapy in acute cellulitis: a systematic review and meta-analysis of the effectiveness and harms of antibiotic treatment. J Infect. 2020;81(4):521-31. doi: https:\/\/doi.org\/10.1016\/j.jinf.2020.07.030","DOI":"10.1016\/j.jinf.2020.07.030"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Lee RA, Centor RM, Humphrey LL et al. Appropriate use of short-course antibiotics in common infections: best practice advice from the American College of Physicians. Ann Intern Med. 2021;174(6):822-7. doi: https:\/\/doi.org\/10.7326\/M20-7355","DOI":"10.7326\/M20-7355"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Hansson C, Faergemann J, Swanbeck G. Fungal infections occurring under bandages in leg ulcer patients. Acta Derm Venereol. 1987;67(4):341-5. Doi: https:\/\/doi.org\/10.2340\/0001555567341345","DOI":"10.2340\/0001555567341345"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"O'Meara S, Cullum NA, Nelson EA. Compression for venous leg ulcers. Cochrane Database Syst Rev. 2009;(1):CD000265. doi: 10.1002\/14651858.CD000265.pub2. Update in: Cochrane Database Syst Rev. 2012;11(11):CD000265. doi: https:\/\/doi.org\/10.1002\/14651858.CD000265.pub3","DOI":"10.1002\/14651858.CD000265.pub3"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Eder S, St\u00fccker M, L\u00e4uchli S et al. Is compression therapy contraindicated for lower leg erysipelas?: Results of a retrospective analysis. Hautarzt. 2021;72(1):34-41. doi: https:\/\/doi.org\/10.1007\/s00105-020-04682-4","DOI":"10.1007\/s00105-020-04682-4"}],"container-title":["Danish Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T10:58:06Z","timestamp":1715770686000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/dmj\/A08230530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":19,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.61409\/a08230530","relation":{},"ISSN":["2245-1919"],"issn-type":[{"value":"2245-1919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,1]]}}}